Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
One-day NEPA plus dexamethasone prophylaxis for chemotherapy-induced nausea and vomiting during AC-based adjuvant chemotherapy in breast cancer
2015-003316-20Phase 2Completed
- Sponsor
- Consorzio Oncotech
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of palonosetron and dexamethasone in chemotherapy-induced nausea and vomiting (CINV), sponsored by Consorzio Oncotech. Primary endpoint: Complete response maintained during overall phase. Started Sep 2021; status: completed.
02
Drugs
palonosetrondexamethasone
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on 2015-003316-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003316-20.